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Abstract.  
The current study reports on the manufacturing by rapid prototyping technique of three-
dimensional (3D) scaffolds based on silicon substituted hydroxyapatite with Elastin-like 
Recombinamers (ELRs) functionalized surfaces. Silicon doped hydroxyapatite (Si-HA), 
with Ca10(PO4)5.7(SiO4)0.3(OH)1.7h0.3 nominal formula, was surface functionalized with 
two different types of polymers designed by genetic engineering: ELR-RGD that 
contain cell attachment specific sequences and ELR-SNA15/RGD with both 
hydroxyapatite and cells domains that interact with the inorganic phase and with the 
cells, respectively. These hybrid materials were subjected to in vitro assays in order to 
clarify if the ELRs coating improved the well-known biocompatible and bone 
regeneration properties of calcium phosphates materials. The in vitro tests shown that 
there were a total and homogeneous colonization of the 3D scaffolds by Bone marrow 
Mesenchymal Stromal Cells (BMSCs). In addition, the BMSCs were viable and able to 
proliferate and differentiate into osteoblasts. 
 
Statement of significance 
Bone tissue engineering is an area of increasing interest because its main applications 
are directly related to the rising life expectancy of the population, which promotes 
higher rates of several bone pathologies, so innovative strategies are needed for bone 
tissue regeneration therapies. Here we use the rapid prototyping technology to allow 
moulding ceramic 3D scaffolds and we use different bio-polymers for the 
functionalization of surfaces in order to enhance the biological response. The combining 
the ceramic material (silicon doped hydroxyapatite, Si-HA) and the Elastin-like 
Recombinamers (ELRs) polymers with the presence of the integrin-mediate adhesion 
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domain alone or in combination with SNA15 peptide that possess high affinity for 
hydroxyapatite provide an improved Bone marrow Mesenchymal Stromal Cells 
(BMSCs) differenciation into osteoblastic linkage.  
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1. Introduction 
The 3-D printing technology has given an extra boost to the world of biomaterials in the 
field of Tissue Engineering, to enable the design and manufacture of prostheses "ad oc" 
for each patient. These new manufacturing techniques of biomaterials for clinical use, 
also give us the ability to toggle various materials and proteins in the manufacturing 
process itself and modify the surfaces of classic biomaterials in a controlled manner. 3D 
rapid prototyping technique is an emerging method in the scaffold design. It is based on 
the direct, layer by layer, slow deposition of a ceramic ink to form a three dimensional 
scaffold. The 3D-plotter used to prepare 3D scaffolds moves along the three directions 
in space while depositing ink strings over a plate. The plotter movements are controlled 
by a computer which makes possible to plot very complex 3D structures. This technique 
has shown that it is possible to prepare 3D scaffolds made of different materials suitable 
for tissue engineering, for example, chitosan-HA or polylactic acid and 
polycaprolactone-HA or polyacrylate-HA [1,2,3]. 
A wide application of these materials is based in their ability to induce bone 
regeneration. The use of grafts is a common technique for filling in bone defects, when 
it is not possible to use native bone, and they are usually based on hydroxyapatite (HA). 
Thus, Vallet et al. have designed a biomaterial (HA) for use in bone regeneration 
cavitary defects in tibia of research animals [4]. More recently, these materials have 
evolved thanks to molecular techniques of replacement including silicon (Si) in its 
structure. These doped with Si (Si-HA), biomaterials are susceptible of being 
functionalized with different peptides, alone or in combination of two or more of them 
that would have synergies and may be complementary in function [5]. 
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These new arising technologies require designing new manufacturing systems and 
modifying the physico-chemical properties of the classical materials. These modified 
biomaterials require the completion of previous studies of biocompatibility and 
tolerance, both in vitro and in vivo. In this sense, the biocompatibility of biomaterials 
based on hydroxyapatite manufactured and its osteogenic capacity is beyond doubt and 
has been described by several authors [6,7]. 
When hydroxyapatite is implanted as bone substitute, the model of wound healing 
involves the activation of periostium connective tissue which is responsible for the 
formation of the fibrous capsule surrounding the biomaterial. This capsule does not 
permit the join between healthy bone ends of the defect. The hydroxyapatite action 
would cause that surrounding connective tissue became in osteoid tissue, probably due 
to the action of osteoblasts from healthy areas that colonizing the fibrous capsule and 
they perform their osteoinductive function onto the fibrous material [7] 
This means, that the performance of these 3-D biomaterials, when implanted in living 
tissue, is variable depending on the nature of peptides that are functionalized with. The 
use of Elastin-like Recombinamers (ELRs) for functionalizing surfaces is a novel 
advance that has been recently proposed. Among the bio-produced polymers, the ELRs, 
are considered a family with a high potential for biomaterials design. 
ELRs are based on repeated sequences, namely “elastomeric domains”, found in an 
extracellular matrix (ECM) protein, the natural elastin [8,9]. ELRs retain the elastin 
mechanical properties, specially its ideal elasticity and outstanding resistance to fatigue 
[10]. Besides, these polymers show unmatched characteristics in terms of 
biocompatibility [11], and combine a strong tendency to self-assemble with an acute 
smart behaviour, depending on the polymeric architecture and environmental conditions 
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[12,13]. Additionally, specific functionalities, such as cell-binding sequences that 
modulate cell adhesion through integrins, and other bioactive functions can be included 
in their structure by adding several peptide domains derived from different extracellular 
matrix (ECM) or non-ECM proteins [14,15].  
Several researchers are studying the role of the RGD sequence in bone biology and they 
are incorporating the use of synthetic RGD peptides to develop new drugs or control the 
bioactivity of the materials used for bone regeneration [16]. According to other authors, 
the chemotactic and adhesive RGD peptide, the action appears to induce migration and 
adhesion of osteoblasts on the surface of the biomaterial implanted in the defect area, 
producing a clear improvement of the bone regeneration process [17,18,19]. 
In this sense, there is an increasing use of small peptides with antimicrobial properties 
that enhance the ability of the biomaterials to induce bone regeneration, while 
preventing the infection caused by their use [20]. In this regard, the antimicrobial role of 
RGD [21] and statherin [22] are described. Statherin, together with proline-rich proteins 
(PRP), salivary α-amylase, mucins, agglutinins, and histatins cystatins, among others, is 
one of the major proteins present in saliva. Statherin is a small protein of 43 amino acids 
that exerts its function by regulating tooth mineralization by controlling the deposition 
of calcium (Ca2+) preventing excessive deposition thereof on tooth enamel [23]. 
Furthermore, statherin has a marked control the bacterial flora present in the oral cavity, 
in conjunction with other proteins present in it and with which it forms a protein 
network that maintains homeostasis in the oral cavity, as has been described by some 
authors [24,25,26], which have also described an important role for some fragments of 
this protein in innate immune response and inflammatory processes that occur in the 
oral cavity. The foregoing features and having the affinity to bind to the statherin and 
mineralized HA, through a domain of 15 amino acids located at the N-terminus 
7 
 
(SNA15), making this protein an ideal candidate for cause and osteoinduction 
osteogenesis in regenerative processes in bone injuries of varying degrees, as has been 
well described Tejeda-Montes et al. in recent paper on calvarian defect in rat [27]. 
In this paper, we present the possibility of exploiting the ability of certain peptides to 
enhance bone regeneration process when they are decorated onto 3D scaffolds. For this 
purpose, the biomaterials are functionalized with chemotactic and adhesive peptides 
with features such as RGD peptide and the peptide comprising the 15 N-terminal 
residues of statherin (SNA15) domain. Therefore, the main objective of our work is the 
study of bone repair effect of hydroxyapatite doped silicon and functionalized with 
adhesion peptides (RGD) and/or peptides with high affinity for hydroxyapatite and a 
marked feature of the process of mineralization (SNA15). 
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2. Materials and methods 
2.1. Synthesis of Si-HA powder  
Nanocrystalline silicon-substituted hydroxyapatite (Si-HA) with the nominal formula 
Ca10(PO4)5.7(SiO4)0.3(OH)1.7h0.3, where h indicates vacancies at the hydroxyl position, 
was prepared by aqueous precipitation reaction of Ca(NO3)2·4H2O, (NH4)2HPO4 and 
Si(CH3CH2O)4 solutions, as described elsewhere [28]. Briefly, a 1 M solution of 
Ca(NO3)2·4H2O was added to solutions of (NH4)2HPO4 and Si(CH3CH2O)4 of 
stoichiometric concentration to obtain the composition described above. The mixture 
was stirred for 12 h at 80 ºC. The pH was kept at 9.5 by NH3 addition. During the 
reaction the pH was continuously adjusted to 9.5 to ensure constant conditions during 
synthesis. The precipitated Si-HA powder was treated at 700 ºC to remove nitrates 
without introducing important changes in the structure and microstructure of the 
materials. Si-HA detailed chemical, structural and microstructural characterization can 
be found in ref. [28]. 
2.2 Polymer Protein Expression and Purification: 
Below are shown the two amino-acid sequences of the ELRs utilized in this work. 
ELR-RGD:  
{MGSSHHHHHHSSGLVPRGSHMESLLP(VPGIG)2(VPGKG)(VPGIG)2]2AVTGR
GDSPASS(VPGIG)2(VPGKG)(VPGIG)2]2]6V} whose molecular weight is 60661 Da. 
ELR-SNA15/RGD:  
{MESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2DDDEEKFLRRIGRFG[(VPGIG)2(VPG
KG)(VPGIG)2]2]4 
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(VPGIG)2(VPGKG)(VPGIG)2]2AVTGRGDSPASS(VPGIG)2(VPGKG)(VPGIG)2]2]4
V} whose molecular weight is 80730 Da 
ELR genes were constructed by standard genetic engineering techniques. The 
recombinamer biosynthesis was carried out using Escherichia coli-based heterologous 
expression system and their purification from the bacterial lysate was performed using 
their temperature responsiveness with cycles of temperature-depending reversible 
precipitations as described elsewhere [29]. Purified ELRs were dialyzed in cold type I 
water and then freeze-dried.  
The purity and molecular weight of ELRs were analyzed by FTIR, SDS-PAGE and 
mass spectroscopy (MALDI-TOF/MS) while, the correctness of sequence was checked 
by amino-acid analysis and 1H-NMR. The transition temperature of each recombinamer 
was measured by Differential Scanning Calorimetry (DSC). 
2.3. Scaffolds of Si-HA powder  
3-D periodic macroporous scaffolds were prepared via direct write assembly of a Si-HA 
slurry, using 3-D rapid prototyping printing equipment (envisionTEC 3D Bioplotter™). 
The slurry was formed by the method described in ref. [30]. Briefly, slow addition 
under stirring of 29 g of Si-HA powder over a solution formed by 3 g Darvan® 811 
(sodium polyacrylate dispersant agent), 2-3 drops of glycerine and 22 mL of aqueous 
solution formed by methacrylamide (MMA) and N,N΄-methylen-bis-(acrylsaeureamid) 
(MBAA). The slurry obtained was housed in a syringe and deposited through a conical 
needle (diameter 0.51 mm) at the volumetric flow rate required to maintain a constant x-
y table speed (v = 3 mm s-1). The final dimensions of the scaffolds were a mesh with 
interconnected cells of 8 mm diameter × 2 mm height for in vitro assays. Once the 
scaffolds were prepared the organic phase employed during the processing stage was 
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thermally removed at 600 ºC for 6 h. These non-coated scaffolds are denoted Si-HA in 
the text below. 
2.4. Functionalizing the Si-HA scaffolds with elastin-like polymers 
Si-HA scaffolds were coated by immersion with two different polymers. An elastin-like 
polymer contained cell attachment specific sequences (RGD domain), samples named 
Si-HA-RGD. And an elastin-like polymer designed specifically with both 
hydroxyapatite binding and cell adhesion domains (HAp adhesion ones; SNA15 of the 
Stathenin) and with the cells (RGD domain), samples named Si-HA-SNA15/RGD. 
Solutions of both polymers were prepared in a 1x Phosphate Buffer Solution (PBS). In 
both cases 10 mg/mL solutions were prepared at 4 ºC and were let overnight until 
complete dissolution of polymers. Afterwards, the scaffolds were immersed on 500 µL 
each polymer solution for one hour with orbital stirring (100 rpm). Then, the coated 
scaffolds were rinsed in PBS and dried at 37 ºC. 
2.5. In vitro tests 
2.5.1. Viability and proliferation test  
Rat Bone marrow Mesenchymal Stromal Cells (rBMSCs) were obtained and processed 
as described elsewhere [31]. They were cultured on three different biomaterials in order 
to clarify their effects on viability and proliferation. Particularly, 50000 rBMSCs were 
seeded on 24 standard well plates TCPS (Tissue Culture Polystyren) or scaffolds 
containing Si-HA, Si-HA-RGD and Si-HA-SNA15/RGD placed in non-adherent well 
plates. It is noteworthy that standard TCPS was used as positive control for viability and 
proliferation. rBMSCs were cultured during 24 h, 11 and 16 days using osteogenic 
medium containing Advanced DMEM supplemented with 15 % Fetal Bovine Serum 
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(FBS), 1 % Penicillin/Streptomycin (Pen/Strep), 1% L-Glutamine (L-Glu), 10 mM β-
glycerophosphate, 50 μg/mL ascorbic acid and 10-8 M dexamethasone. Once reached 
the period of time, cells were lysed using M-PER (Pierce). M-PER was allowed to react 
during 15 min in a shaker at 4 ºC. Afterwards, cellular suspensions were centrifuged at 
2500 g during 10 min at 4 ºC. The supernatants were stored at -20ºC prior to analysis. 
To estimate the number of cells per sample it was used the cytotoxicity detection kit 
Lactate dehydrogenase (LDH) manufactured by Roche. This kit is based on the 
measurement of the LDH activity to quantify the number of cells. Quantification was 
performed following the instructions of the manufacturer. 
2.5.2. Cell colonization of scaffolds  
50000 rBMSCs transfected with the green fluorescent protein (GFP) were seeded on Si-
HA, Si-HA-RGD and Si-HA-SNA15/RGD and cultured during 3 days using standard 
culture medium for BMSCs (Advanced DMEM, 15 % FBS, 1% Pen/Strep and 1% L-
Glu). Once reached the culture period images on the top and inside of the scaffolds were 
acquired using a Leica fluorescent stereomicroscope. To get the inside images scaffolds 
were transversally split by mean of a scalpel.  
2.5.3 Alkaline Phosphatase (ALP) Activity 
The alkaline phosphatase (ALP) is a very well-known bone marker involve in the 
process of bone mineralization. The ALP activity, it was measured by means of the 
Sensolyte pNPP Alkaline Phosphatase Kit from ANESPEC. Same cellular supernatants 
obtained in the 2.5.1 section were used as samples in the current assay. Quantification 
protocol suggested by the manufacturer of the Kit was followed. 
2.5.4. Osteocalcin ELISA 
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As well as ALP, Osteocalcin (OC) plays an important role in bone mineralization, and 
is a widely known marker for osteoblasts. In order to reveal the differentiation of 50000 
rat BMSCs cultured on TCPS, Si-HA, Si-HA-RGD and Si-HA-SNA15/RGD, the 
Osteocalcin rat ELISA (Demeditec Diagnostic GmbH) was used. OC was measured at 
7d, 11d and 16d. To avoid the FBS interference and to synchronize the cells the culture 
medium was changed 24 h before the measurement. Cells were washed twice with PBS 
and then osteogenic medium FBS reduced (1% FBS) was added. Once reached the 
desired period of time, the supernatant was collected and stored at -20ºC prior to 
analysis. The quantification was performed following the protocol provided by the 
manufacturer.  
All in vitro assays data are representative of at least three independent experiments, 
each containing 2-3 replicates, except when otherwise noted. Results are expressed as 
the mean ± SEM. Statistical significance was determined using a two-way analysis of 
variance followed by a post hoc Bonferroni’s correction (p < 0.05). 
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3. Results and Discussion 
The efficiency of production and purification were verified through chemical 
characterizations of the biosynthesized ELRs. FTIR, 1H-NMR (data not shown) and the 
SDS-PAGE electrophoresis (Figure 1) of purified ELRs sample confirmed their purity. 
Figure 2 shows the MALDI-TOF mass spectrum of ELR-SNA15/RGD, experimental 
molecular weight found by this technique matches the expected molecular weight of the 
recombinamer (Mw = 80730 Da) within the experimental error, while the peak at 40535 
is due to the doubly charged species. The measured amino-acid content of ELR-
SNA15/RGD matched well its theoretical composition (see Table 1). The results of the 
MALDI-TOF and amino-acid analysis for ELR-RGD can be seen in ref. [32]. 
Biosynthesis yield of both purified ELRs was about 300 mg/L of bacterial culture.  
The utility of Si-doped hydroxyapatite (Si-HA) as an excellent material in the field of 
bone tissue regeneration has been previously showed due to its biocompatibility, 
bioactivity and osteoconductivity [33,34]. With the aim to ensure improved biological 
response in terms of osseointegration and scaffold resorption, ELRs were incorporated 
to Si-HA scaffolds surface. These bioactive scaffolds based on silicon-substituted 
hydroxyapatite were prepared via direct write assembly of Si-HA slurry, using 3-D 
rapid prototyping printing technique. This strategy allows the design of the porous 
arrangement, thus controlling size, volume and connectivity pattern of the scaffolds. 
Recombinamers were adsorbed on the microporous calcium phosphate bioceramic 
scaffolds by dipping the Si-HA scaffolds in 10 mg/mL 1x PBS solutions of ELR-RGD 
and ELR-SNA15/RGD, respectively. The percentage of ELRs incorporation to Si-HA 
scaffolds was estimated from thermogravimetric measurements and the values obtained 
were around 2 per cent. 
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The first recombinamer used shows a simpler composition. Its bioactivity and potential 
for biofuncionalization relies on the presence of the RGD cell adhesion integrin-mediate 
domain, derived from human fibronectin. The benefits of such surface treatment on the 
ceramic compound are evident. The promotion of early osteoblast addition, induced by 
the presence of RGD domains on the ceramic surface, would speed the osseointegration 
of the implant. However, this simple approach is not free of certain risks of lack of 
efficiency. As the surface functionalization relies on the passive adsorption of the ELR-
RGD, two complications might arise. The first one being an insufficient degree of 
adsorption of the ELR-RGD on the ceramic surface, limiting so its final ability for cell 
adhesion and rapid and homogeneous osseointegration. Other complication that might 
take place is due to the highly charged feature of the RGD domain. It could be the case 
that adsorption on the polar ceramic might preferentially take place by those RGD 
domains, preventing them to be readily available for cell adhesion and decreasing so 
their efficiency. 
To avoid those two potential complications, a new ELR has been designed and used in 
this work; namely ELR-SNA15/RGD This particular ELR has a diblock architecture in 
which two different functionalities are associated to both blocks. The first block is quite 
similar in composition and bioactivity to ELR-RGD. That block contains the RGD 
domain and will bear cell-adhesion functionality. The other block contains a different 
bioactive domain. That is based on the SNA15 specific sequence found on the human 
salivary protein statherin.  
Salivary statherin has a high affinity for calcium phosphate [35,36,37,38]. The amino-
terminal 15-residue fragment (SN15) and its analog (SNA15) exhibit a higher affinity 
for HAP than the entire statherin molecule due to the negative charge density and 
helical conformation present in the fragment. Previous studies also demonstrated the 
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ability of these fragments to adsorb at hydroxyapatite [39]. The SN15 and SNA15 
fragments are thus attractive candidates for incorporation into ELRs for the synthesis of 
biocompatible and biofunctional calcium phosphate hybrid materials. 
According to that, the ELR-SNA15/RGD di-block would make use of the SNA15 block 
for active, efficient, strong and massive adsorption of the ELR-SNA15/RGD on the 
calcium phosphate surface of the ceramic implant. Being the recombinamer adsorption 
now driven primarily by the SNA15 block, the RGD block would be now abundant and 
free for promoting efficient cell-binding activity on ceramic surface. Therefore, the 
recombinamer ELR-SNA15/RGD has been designed as a kind of ideal functional 
interface between the inorganic phase and the biological (cellular) phase.  
In vitro studies will test that working hypothesis by comparing the osseointegration of 
the bare ceramic scaffold and those scaffolds on which both ELR-RGD and ELR-
SNA15/RGD had been adsorbed. The differential cellular behaviour on the three 
scaffolds will used as a test for this working hypothesis. 
3.1. Viability and proliferation  
Results from the LDH assay demonstrated that the proliferation rates of rBMSCs 
cultured on Si-HA, Si-HA-RGD or Si-HA-SNA15/RGD are statistically the same Figure 
3. The most striking result to emerge from the data is that BMSCs were capable to 
growth on Si-HA, Si-HA-RGD and Si-HA-SNA15/RGD and the elastomeric 
components did not affect to the proliferation rate. 
3.2. BMSCs colonization of scaffolds 
The colonization test was performed in order to clarify if rBMSCs are able to colonize 
the entire scaffold or the cell attachment is limited to the most external layers. 
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Particularly, in the Figure 4 it is shown that rBMSCs were able to colonize 
homogeneously the entire scaffolds (top and inside views). Likewise the results from 
the proliferation assay, there was not found any difference between Si-HA, Si-HA-RGD 
or Si-HA-SNA15/RGD.  
3.3. Differentiation of BMSCs into osteoblasts  
In order to evaluate the osteoblast differentiation of rBMSCs it was measured the 
functional expression of two well-known osteoblast markers (OC and ALP). The Figure 
5A are presented the results related with the OC ELISA test, the findings reveal that the 
peak in the expression of OC was expressed by rBMSCs cultured on Si-HA-
SNA15/RGD (4.01x10-8 ng/cell). Particularly, it is remarkably that the maximum 
expression of OC it was obtained at 7 days of culture, which is an early expression for 
this protein. This effect can be correlated to ALP activity Figure 5B it is shown that the 
maximum ALP activity (1.92x10-5 ng·min/cell) was reached by cells seeded on Si-HA-
SNA15/RGD during 16 days. In contrast with colonization and viability tests, in the 
ALP activity were observed significant differences between TCPS, Si-HA, Si-HA-RGD 
and Si-HA-SNA15/RGD. This finding suggests that even if cells are able to grow in any 
surface tested, the cell behavior is different. Current differentiation assays demonstrate a 
positive effect of Si-HA-SNA15/RGD guiding the rBMSCs into the osteoblastic lineage. 
Previous studies with the ELR-RGD correlate well with the results found in this study 
and supports that the availability of the RGD motifs to the cells promotes osteoblast 
differentiation of the rBMSCs [40]. 
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4. Conclusion 
In summary, we have developed an innovative scaffold for bone tissue regeneration. 
Rapid prototyped Si-HA scaffolds have been biofunctionalized by the absorption of the 
bioactive protein polymers ELRs and the cell-material interaction of mesenchymal stem 
cells has been studied. The presence of the integrin-mediate adhesion domain alone or 
in combination with SNA15 peptide that possess high affinity for hydroxyapatite have 
not determined an increase of cells proliferation rate and analogous viability was 
observed. The Si-HA, Si-HA-RGD and Si-HA-SNA15/RGD scaffolds are able to 
support the cell culture growth in a similar manner. Instead of that, ability of the three 
scaffolds of inducing mesenchymal stem cells differentiation into the osteoblastic 
lineage was statistically different. Differentiation studies reveal a positive effect of Si-
HA-SNA15/RGD guide the mesenchymal stem cells into the osteoblastic lineage which 
make them excellent candidates for future in vivo assays.  
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Figure Captions 
Figure 1. SDS-polyacrilamide gel electrophoresis. Lane M: Molecular standards, 
numbers on the right indicate the corresponding apparent MW values of the standard (in 
kDa). Lane 1: purified ELR-RGD. Lane 2: purified ELR-SNA15/RGD. 
Figure 2. Mass spectra (MALDI-TOF/MS) of ELR-SNA15/RGD. 
Figure 3. Viability and proliferation assays obtained by LDH activity measurements of 
BMSCs cultured on TCPS (positive control), Si-HA, Si-HA-RGD and Si-HA-
SNA15/RGD at different times.  
Figure 4. Different views of Si-HA, Si-HA-RGD and Si-HA-SNA15/RGD scaffolds 
colonized by human BMSCs transfected with the green fluorescent protein (GFP). 
Figure 5. OC and ALP activity of BMSCs on the TCSP (positive control), Si-HA, Si-
HA-RGD and Si-HA-SNA15/RGD scaffolds after 7, 11 and 16 days of incubation. 
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Tables 
Table 1. Theoretical and measured amino acid compositions of ELR-SNA15/RGD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
residue theoretical measured
Asp 16 16,88 
Ser 13 11,27 
Glu 9 10,04 
Gly 340 334,66 
Ala 8 6,77 
Val 165 164,41 
Met 1  
Ile 132 134,79 
Leu 6 8,6 
Thr 4 3,23 
Phe 8 8,91 
Lys 36 37,87 
Arg 16 17,19 
Pro 165 166,29 
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